Literature DB >> 28360506

Current trends of microorganisms and their sensitivity pattern in paediatric septic arthritis: A prospective study from tertiary care level hospital.

Girish Motwani1, Rujuta Mehta1, Alaric Aroojis1, Sandeep Vaidya1.   

Abstract

PURPOSE: Early treatment of septic arthritis is essential before irreversible damage to the articular cartilage occurs. Clinicians often start empirical antibiotic therapy for symptomatic relief while awaiting a definitive culture report. In present day parlance with variations in different centres in the private and public sector and rampant antibiotic abuse, a lot of resistance is being seen in the flora and their sensitivity patterns. Hence it is imperative to document and analyze these changing trends.
METHODS: The authors conducted a retrospective analysis of prospectively gathered data of 60 patients under 14 years of age. Joint arthrotomy was performed as a standard therapeutic protocol and the drained pus or synovial fluid was sent for gram stain and culture by 2 different methods: conventional agar plate method and BACTEC Peds Plus/F bottle method. Antibiotic susceptibility tests were done by the disc diffusion method of Clinical Laboratory Standards Institute (CLSI).
RESULTS: The commonest presenting age group was below 1 year (80% patients) including 24 neonates. There were 19 hospital and 41 community acquired cases of septic arthritis. The hip (56%) was the commonest affected joint followed by knee (28%), shoulder joint (11%) and elbow (5%). Microorganism was isolated in 53% isolates of joint fluid only (36 culture positive patients). Conventional agar methods of culture showed positive report in only 42% patients (15/36 patients) while with the BACTEC method the yield was 71%. In the Community acquired septic arthritis, methicillin sensitive Staphylococcus aureus was isolated as commonest microbe while resistant variety of gram negative bacilli including E. coli and Klebsiella were found as predominant organism causing hospital acquired nosocomial infection of joints. The results strikingly differ in terms of response to treatment as most patients (11/19 patients) showed significant resistance to the most commonly practiced empirical antibiotic regimen of ampicillin-cloxacillin group in routine practice. When cefazolin was used as empirical antibiotic, it has shown good response and better sensitivity in 82% patients (27/33 patients).
CONCLUSION: S. aureus is still the most common organism in septic arthritis. The BACTEC system was found to improve the yield of clinically significant isolates. Though a significant resistance to common antibiotic regimen is noticed, the strain is susceptible to cephalosporin group of antibiotics. We recommend the use of cephalosporine antibiotics as an empirical therapy till culture and sensitivity report are available.

Entities:  

Keywords:  Aureus; BACTEC; Cephalosporine; Septic arthritis; Staphylococcus

Year:  2016        PMID: 28360506      PMCID: PMC5359515          DOI: 10.1016/j.jcot.2016.09.001

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  11 in total

1.  Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid.

Authors:  J G Hughes; E A Vetter; R Patel; C D Schleck; S Harmsen; L T Turgeant; F R Cockerill
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Culture of joint specimens in bacterial arthritis. Impact of blood culture bottle utilization.

Authors:  R von Essen
Journal:  Scand J Rheumatol       Date:  1997       Impact factor: 3.641

3.  Serum C-reactive protein, erythrocyte sedimentation rate and white blood cell count in septic arthritis of children.

Authors:  M J Kallio; L Unkila-Kallio; K Aalto; H Peltola
Journal:  Pediatr Infect Dis J       Date:  1997-04       Impact factor: 2.129

4.  Bone and joint infection in neonates.

Authors:  A Narang; K Mukhopadhyay; P Kumar; O N Bhakoo
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

5.  Neonatal septic arthritis.

Authors:  D Halder; Q B Seng; A S Malik; K E Choo
Journal:  Southeast Asian J Trop Med Public Health       Date:  1996-09       Impact factor: 0.267

6.  Septic arthritis in patients followed-up in neonatal intensive care unit.

Authors:  Sevki Kabak; Mehmet Halici; Mustafa Akcakus; Neside Cetin; Nazmi Narin
Journal:  Pediatr Int       Date:  2002-12       Impact factor: 1.524

7.  Septic arthritis in children: relationship of causative pathogens, complications, and outcome.

Authors:  Chun-Lung Wang; Shih-Min Wang; Yao-Jong Yang; Ching-Hsiang Tsai; Ching-Chuan Liu
Journal:  J Microbiol Immunol Infect       Date:  2003-03       Impact factor: 4.399

8.  Joint effusion in children with an irritable hip: US diagnosis and aspiration.

Authors:  J K Zawin; F A Hoffer; F F Rand; R L Teele
Journal:  Radiology       Date:  1993-05       Impact factor: 11.105

Review 9.  Pediatric osteoarticular infection update.

Authors:  Nicole I Montgomery; Scott Rosenfeld
Journal:  J Pediatr Orthop       Date:  2015-01       Impact factor: 2.324

Review 10.  The management of septic arthritis in children: systematic review of the English language literature.

Authors:  S-N Kang; T Sanghera; J Mangwani; J M H Paterson; M Ramachandran
Journal:  J Bone Joint Surg Br       Date:  2009-09
View more
  3 in total

1.  Current clinical and bacteriological profile of septic arthritis in young infants: a prospective study from a tertiary referral centre.

Authors:  Gireesh Sankaran; Balaji Zacharia; Antony Roy; Sulaikha Puthan Purayil
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-02-09

2.  Septic Arthritis of Neonates: Descriptive Study of a Neonatal Intensive Care Unit Nosocomial Outbreak.

Authors:  Nachappa Sivanesan Uthraraj; Srushti Sahukar; Meghana Prakash Hiriyur Prakash; Laya Manasa Sriraam; Siddharth Virani; Gowdar Guruprasad; Jai Relwani
Journal:  Cureus       Date:  2022-04-27

Review 3.  Global epidemiology of childhood bone and joint infection: a systematic review.

Authors:  Sarah Hunter; Heidi Chan; Joseph F Baker
Journal:  Infection       Date:  2022-01-20       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.